NEW YORK (GenomeWeb News) – ChanTest has won a $4.8 million grant from the State of Ohio that it plans to use to expand its G-protein coupled receptor and ion channel products and services, the company said today.

The Cleveland-based company received the competitive grant through Ohio's Third Frontier Research and Commercialization Program

The company plans to use the funds to expand its library of validated ion channel and GPCR cell line products and services, and on its electrogenic transporter and stem-cell derived heart cell services.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.